ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
18
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,310
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes.
Author(s):
D Sommeijer
,
A Leyte
,
K Vet-Joop
,
Fred H Cate
,
Pieter Reitsma
Publication date:
2005-05-31
Journal:
Journal of Thrombosis and Haemostasis
Keywords:
Adolescent
,
Adult
,
Aged
,
Aged, 80 and over
,
Blood Platelets
,
ultrastructure
,
Cholesterol
,
blood
,
Cross-Over Studies
,
Diabetes Mellitus, Type 2
,
Female
,
Humans
,
Integrin beta3
,
analysis
,
drug effects
,
Macromolecular Substances
,
chemistry
,
Male
,
Middle Aged
,
Platelet Activation
,
Pravastatin
,
pharmacology
,
therapeutic use
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via crossref license)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
EPA CompTox Chemicals Dashboard
Author and article information
Journal
PubMed ID::
15946206
DOI::
10.1111/j.1538-7836.2005.01403.x
ScienceOpen disciplines:
Chemistry
Keywords:
Adolescent
,
Adult
,
Aged
,
Aged, 80 and over
,
Blood Platelets
,
ultrastructure
,
Cholesterol
,
blood
,
Cross-Over Studies
,
Diabetes Mellitus, Type 2
,
Female
,
Humans
,
Integrin beta3
,
analysis
,
drug effects
,
Macromolecular Substances
,
chemistry
,
Male
,
Middle Aged
,
Platelet Activation
,
Pravastatin
,
pharmacology
,
therapeutic use
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adolescent
,
Adult
,
Aged
,
Aged, 80 and over
,
Blood Platelets
,
ultrastructure
,
Cholesterol
,
blood
,
Cross-Over Studies
,
Diabetes Mellitus, Type 2
,
Female
,
Humans
,
Integrin beta3
,
analysis
,
drug effects
,
Macromolecular Substances
,
chemistry
,
Male
,
Middle Aged
,
Platelet Activation
,
Pravastatin
,
pharmacology
,
therapeutic use
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,310
PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications
Authors:
Pascal Goldschmidt-Clermont
,
Glen E Cooke
,
Gregory Eaton
…
Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients.
Authors:
D. Mohanty
,
Shrimati D. Shetty
,
Arathy D. S. Nair
…
Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study
Authors:
D. Feng
,
K Lindpaintner
,
MG Larson
…
See all similar
Cited by
16
Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis
Authors:
Xianming Mo
,
Sheyu Li
,
Jia Wei
…
Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases
Authors:
Yan Chen
,
Guangping Li
,
Ming-Lin Liu
Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis
Authors:
Lina Badimon
,
Rosa Suades
,
Eduardo Fuentes
…
See all cited by